JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $340

Benzinga · 4d ago
JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $350 to $340.